Anti-wrinkle composition with sodium DNA and RNA
By using anti-wrinkle compositions of sodium DNA and RNA, the skin regeneration ability and the neurotransmitter release are activated, and the problems of slow and irritating effects of existing anti-wrinkle products are solved, achieving rapid lightening and long-lasting smoothing effects.
Patent Information
- Application Number
- CN202410933614.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-12
AI Technical Summary
The ingredients of precious animal and plant extracts in existing anti-wrinkle products are complex and have inaccurate effects. The high amount of added content has problems with skin tolerance, retinol and other irritating properties, and the anti-wrinkle effect is slow and not long-lasting.
Provided an anti-wrinkle composition with sodium DNA and RNA, including polydeoxyribonucleotides, collagen, ribonucleic acid RNA, antioxidants, moisturizers, thickeners, diluents and preservatives, by activating the inherent regeneration of the skin Ability and inhibit neurotransmitter release, achieving rapid light lines anti-wrinkle and long-lasting smoothness.
It achieves rapid light lines and anti-wrinkle, lasting and keeps the skin delicate and smooth, gentle and non-irritating, suitable for sensitive skin, significantly improves facial wrinkles and skin sagging, and has good moisturizing and firming effects.
Smart Images

Figure CN118924647A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an anti-wrinkle composition, in particular to an anti-wrinkle composition comprising sodium DNA and RNA, and belongs to the technical field of production and manufacturing of anti-wrinkle cosmetics. Background Art
[0002] As people age, and under the influence of genetic, environmental and other factors, the metabolism of human skin will gradually slow down, resulting in a decrease in water and subcutaneous fat, coarsening of elastic fibers, and loss of luster, ultimately leading to the formation of skin wrinkles.
[0003] According to the principle of skin wrinkles, they can be divided into static wrinkles and dynamic expression lines, among which:
[0004] Static wrinkles are caused by the lack of collagen and elastin, which leads to sagging skin and local folding. The upper face skin is sagging, which leads to lower eyelid wrinkles, nasolabial wrinkles, cheek wrinkles and neck wrinkles. The age of appearance is mainly around 40 years old, and then the face will gradually leave permanent static wrinkles.
[0005] The cause of dynamic expression lines is the surface skin wrinkles caused by muscle contraction and traction when people make facial expressions. These mainly include frown lines, forehead wrinkles, crow's feet, etc. In addition to the natural aging factors of the skin, more importantly, they are caused by excessive contraction of the facial muscles. They appear at around the age of 20.
[0006] Wrinkles are a typical symptom of skin aging and a manifestation of loss of skin elasticity. They have always been a pain point of concern for people.
[0007] Although skin aging is an irreversible physiological phenomenon, its progression can be delayed or slowed down.
[0008] The most commonly used way to delay or slow down facial wrinkles is to apply anti-wrinkle cosmetics. Currently, there are many types of anti-wrinkle cosmetics, such as:
[0009] The invention patent application "A multi-peptide anti-aging repair mask essence and its preparation method" (application number: CN201510009980.6) discloses a mask essence containing seven peptide active ingredients, which can effectively improve the contour of facial skin, fight fine lines, restore firmness and elasticity, make the skin tender and smooth, and change the overall condition of facial skin;
[0010] The invention patent application "A cosmetic" (application number: CN201710215761.2) is composed of polypeptides, lanolin, vaseline, squalane, glyceryl monostearate, castor oil, whitening agent, glycerin, sodium chondroitin sulfate, anthocyanin, etc. It can remove sun spots, has a significant effect on improving skin tension and anti-wrinkle, and also has the effect of whitening the skin;
[0011] Invention patent application "A skin care composition with the functions of repairing, regenerating, moisturizing and delaying aging" (application number: CN201711162611.6), including extracts of Dendrobium officinale, aloe vera, bergamot, Centella asiatica, chayote, Selaginella, etc., as well as oligopeptides, cosmetic excipients and cosmetic bases;
[0012] The invention patent "Anti-wrinkle composition and anti-wrinkle cream" (application number: CN202011544525.3) includes extracts of polygonatum, cornus officinalis and kumquat, which can block the voltage-dependent Nav1.4 channel on the cell membrane in the muscle, thereby affecting the release of ions, easily penetrating the skin, and significantly relaxing excessive single muscle tension, and can also relieve and improve existing wrinkles;
[0013] The invention patent application "A scorpion venom polypeptide and its use in whitening and anti-wrinkle cosmetics or medicines" (application number: CN202410322953.3) extracts scorpion venom from scorpions, and obtains scorpion venom antioxidant polypeptide 7-C3-5 with good antioxidant properties through enzymatic hydrolysis, ultrafiltration separation, column separation and other methods. It has good antioxidant properties and can also enhance the effects of skin moisturizing and elasticity, thereby achieving better skin anti-wrinkle effects;
[0014] Invention patent application "Skin care active ingredients, skin care products" (application number: CN202410115384.5), the anti-wrinkle firming agent includes at least one of acetyl hexapeptide-8, tripeptide-1, acetyl octapeptide-3 snake venom peptide, palmitoyl tripeptide-5, palmitoyl tripeptide-1, palmitoyl hexapeptide-12, acetyl tetrapeptide-11, and hexapeptide-3, the moisturizing agent includes at least one of ceramide NP, hydrolyzed sodium hyaluronate, and sodium hyaluronate, and the moisturizing firming agent includes at least one of hydrolyzed lupine protein and XVII collagen;
[0015] The invention patent application "Anti-wrinkle and firming composition and its application in cosmetics" (application number: CN202410227711.6) contains recombinant collagen, collagen extract, soluble collagen, collagen amino acids, bakuchiol and seaweed extract, achieving good anti-wrinkle and firming effects;
[0016] The invention patent application "A recombinant humanized type XVII collagen, preparation method and application" (application number: CN202410390651.X) connects humanized type XVII collagen and skin repair polypeptide through a flexible amino acid connecting peptide to form a multifunctional protein, which has great application prospects in skin anti-wrinkle, firming, moisturizing and / or whitening;
[0017] The invention patent application "An anti-wrinkle active composition and its application, anti-wrinkle cream" (application number: CN202410428860.9) is composed of recombinant type III collagen, alpine edelweiss extract, ginsenoside CK and acetyl hexapeptide-8, which can prevent and reduce wrinkles on the face, scalp and neck skin, restore skin elasticity, enhance collagen strength, enhance skin barrier function and hydration and moisturizing effects.
[0018] It can be seen from the above-mentioned anti-wrinkle products that the anti-wrinkle products in the prior art contain a variety of ingredients, such as extracts of various precious animals and plants, and ingredients such as polypeptides, retinol, i.e., vitamin A, and xylose derivative phosphodiesterone.
[0019] However, the extracts of precious animals and plants have complex ingredients and their anti-aging effects are not certain. High amounts of extracts added cause skin tolerance issues and may clog hair follicles and damage the skin. Retinol and other substances are skin irritants. Bosera and peptides are relatively mild, but their anti-wrinkle effects are slow and not long-lasting. Summary of the invention
[0020] In order to overcome the deficiencies of the prior art and meet people's desire to delay and slow down skin aging, maintain its delicate and smooth, youthful and beautiful appearance, the present invention provides an anti-wrinkle composition with sodium DNA and RNA, so as to effectively delay the aging of human facial skin, enhance its elasticity, achieve the purpose of quickly fading lines and wrinkles and keeping the skin delicate and smooth for a long time.
[0021] To achieve the above object, the present invention provides the following technical solutions:
[0022] An anti-wrinkle composition containing sodium DNA and RNA, which is used for rapid wrinkle lightening and wrinkle reduction and long-lasting smoothness maintenance of human facial skin, comprising:
[0023] Polydeoxyribonucleotides (sodium DNA) and collagen as anti-wrinkle agents, ribonucleic acid (RNA) as neurotransmitter inhibitors, and antioxidants, moisturizers, thickeners, diluents, pH adjusters and preservatives that can be added to cosmetics.
[0024] The polydeoxyribonucleotide is sodium DNA derived from yeast fermentation, and can also be polydeoxyribonucleotide derived from salmon, referred to as PDRN, with an average molecular weight of 1 to 50,000 kDa, preferably PDRN derived from salmon, and with a molecular weight of ≤1000 kDa.
[0025] The RNA is produced by biosynthesis and can effectively inhibit the release and transmission of the neurotransmitter acetylcholine, thereby inhibiting expression lines.
[0026] The collagen is derived from human collagen and may be type I, type III or a combination of the two.
[0027] The antioxidant is p-hydroxyacetophenone, ergothioneine, astaxanthin, sodium pyrosulfite, tocopherol acetate, etc., preferably p-hydroxyacetophenone.
[0028] The moisturizing agent is sodium hyaluronate, trehalose, betaine, xylitol, panthenol, tetrahydromethylpyrimidine carboxylic acid, glyceryl glucoside, methyl gluceth-20, sodium PCA, amino acid moisturizing agent, niacinamide, urea, diglycerin, etc., preferably sodium hyaluronate; the moisturizing agent can also be selected from polyol moisturizing agents such as glycerol, butylene glycol, 1,2-pentanediol, 1,3-propylene glycol, isopentyl glycol, 1,2-hexanediol, sorbitol, diglycerin, etc., preferably glycerol, butylene glycol, 1,2-pentanediol.
[0029] The thickener is sclerotium gum, xanthan gum, cellulose, crispy chondrus crispus and carbomer, etc., preferably sclerotium gum and carbomer; the diluent is water; the pH adjuster is arginine, sodium hydroxide, potassium hydroxide, and organic base tromethamine; the preservative is phenoxyethanol, caprylyl glycol, ethylhexylglycerin, glyceryl caprylate, and caprylhydroxamic acid, preferably glyceryl caprylate and caprylhydroxamic acid.
[0030] Preferred:
[0031] The antioxidant is p-hydroxyacetophenone, the moisturizer is sodium hyaluronate, glycerin, butylene glycol and 1,2-pentanediol, the thickener is sclerotium gum and carbomer, the diluent is water, the pH adjuster is arginine, and the preservative is glyceryl caprylate and caprylhydroxamic acid.
[0032] Preferred:
[0033] 100 mL of the anti-wrinkle composition having sodium DNA and RNA contains 0.50 to 0.52 g of the polydeoxyribonucleotide ((abbreviated as sodium DNA, DNA-Na, PDRN)), 0.10 to 0.12 g of the collagen, 0.010 to 0.012 g of the ribonucleic acid (RNA), 0.50 to 0.52 g of the p-hydroxyacetophenone, and 0.05 to 0.06 g of the sodium hyaluronate. , containing 6.0-6.2g of glycerol, 4.0-4.2g of butylene glycol, 3.0-3.2g of 1,2-pentanediol, 0.10-012g of sclerotium gum, 0.10-0.12g of carbomer, 0.10-0.12% of arginine, 0.30-0.32g of glycerol caprylate, caprylhydroxamic acid and 1,3-propylene glycol in total, and the rest is water.
[0034] Furthermore, the anti-wrinkle composition containing sodium DNA and RNA is a clear purple to purple-red transparent liquid, with a pH value of 6.5 to 7.5 and a relative density of 1.02 to 1.04 at 20°C.
[0035] Further:
[0036] According to the requirements of Chapter 4 of the National Standard of the People's Republic of China "Technical Specification for Safety of Cosmetics" (2015 edition), the mercury content is ≤1mg / kg, the lead content is ≤10mg / kg, the arsenic content is ≤2mg / kg, and the cadmium content is ≤5mg / kg.
[0037] Further:
[0038] According to the provisions of Chapter 5 of the National Standard of the People's Republic of China "Technical Specification for Safety of Cosmetics" (2015 edition), the total colony count is ≤1000CFU / g, the total number of molds and yeasts is ≤100CFU / g, and the heat-resistant coliform group, Staphylococcus aureus and Pseudomonas aeruginosa shall not be detected.
[0039] Furthermore, the anti-wrinkle composition comprising sodium DNA and RNA is prepared by the following method:
[0040] Put the diluent in a preparation pot, slowly sprinkle carbomer as a thickener, and pre-disperse sodium hyaluronate, glycerin, butylene glycol as a moisturizer and sclerotium gum as a thickener to prepare a uniformly dispersed mixture, then add the mixture to the preparation pot, stir and heat, then add 1,2-pentanediol as a moisturizer and an antioxidant, continue stirring until the materials in the preparation pot are uniform, then cool down for the first time, then add a pH adjuster to adjust the pH, cool down for the second time, then add a preservative, a neurotransmitter inhibitor, an anti-wrinkle agent and other materials as thickeners and moisturizers, continue stirring until uniform, let stand, and then filter with a sieve to obtain the product.
[0041] Preferred:
[0042] In the method for preparing the anti-wrinkle composition containing sodium DNA and RNA, the heating temperature is 70-75°C, the first cooling temperature range is 50-55°C, and the second cooling temperature range is below 40°C.
[0043] Preferred:
[0044] In the method for preparing the anti-wrinkle composition containing sodium DNA and RNA, the stirring speed is 5 to 50 r / min, and the filtration screen specification is 200 meshes.
[0045] Preferred:
[0046] In the method for preparing the anti-wrinkle composition containing sodium DNA and RNA, the preparation pot is a stainless steel steam heating pot with a stirring device.
[0047] Compared with the prior art, the present invention has outstanding beneficial effects and significant improvements in that:
[0048] 1) The anti-wrinkle composition with sodium DNA and RNA provided by the present invention comprises polydeoxyribonucleotides and collagen as anti-wrinkle agents, ribonucleic acid RNA as a neurotransmitter inhibitor, and antioxidants, moisturizers, thickeners, diluents, pH regulators and preservatives that can be added to cosmetics. Among them, among the polydeoxyribonucleotides (sodium DNA, DNA-Na, PDRN for short) and collagen as anti-wrinkle agents, sodium DNA is a skin cell repair activator that can quickly activate the inherent regeneration ability of the skin and activate the production of collagen, while collagen can regulate the internal and external balance of fibroblasts, stimulate the production of type I and III collagen, support the epidermis to stretch the dermis, and activate skin vitality in both directions, and has a good effect of delaying skin aging and enhancing skin elasticity, while ribonucleic acid RNA as a neurotransmitter inhibitor can effectively inhibit the release of the neurotransmitter acetylcholine and inhibit expression lines. The composition obtained by the organic and exquisite combination of these functional effective ingredients can make the facial skin of the human body quickly lighten lines and wrinkles and keep it smooth for a long time after simple application;
[0049] 2) The anti-wrinkle composition with sodium DNA and RNA provided by the present invention has been tested and proven to meet the requirements of the "Technical Specifications for Safety of Cosmetics" (2015 edition) in terms of various physical and chemical indicators, and no adverse reactions occur after use, which meets the safety standards for cosmetics;
[0050] 3) The anti-wrinkle composition with sodium DNA and RNA provided by the present invention is mild and non-irritating, and is suitable for people with sensitive skin. During use, it is refreshing, non-sticky, easy to absorb, and will not feel dry or tight. The skin feels more moisturized, more moisturizing, stronger, more lustrous, more tender, and more hydrated and translucent. It has obvious moisturizing effect, and the skin will be more delicate, smooth, and full. It can improve skin roughness and reduce facial dry lines and fine lines, and improve facial wrinkles, which is reflected in the improvement of facial wrinkles such as crow's feet, wrinkles under the eyes, forehead fine lines, forehead wrinkles, nasolabial folds, Sichuan-shaped lines, corners of the mouth, and bridge of the nose. It has excellent anti-wrinkle effect, and the skin will be firmer and more elastic, with firming effects such as improving skin sagging, and soothing effects such as improving skin redness, itching, and burning sensations;
[0051] 3) The anti-wrinkle composition with sodium DNA and RNA provided by the present invention has a clear grasp of the mechanism of wrinkle generation on human skin, a simple and clear formula, and appropriate and reasonable compatibility. Therefore, it is mild and soothing, has good effects, is simple to prepare, and is easy to use. Compared with the existing technology, it has outstanding beneficial effects and significant improvements. Therefore, it is of great promotion and application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0052] In order to more clearly illustrate the technical solution of the present invention and the technical effects of implementing the present invention, the following briefly introduces the drawings used in the embodiments of the present invention.
[0053] The obvious:
[0054] The drawings described below are only drawings of some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative work, but these other drawings also belong to the drawings required for use in the embodiments of the present invention, among which:
[0055] Figure 1 This is a bar graph showing the change in the average length of eye wrinkles 4 hours after the test substance was used;
[0056] Figure 2 This is a bar graph showing the change in the average width of eye wrinkles 4 hours after the test substance was used;
[0057] Figure 3 This is a bar graph showing the change in the average depth of eye wrinkles 4 hours after the test substance was used;
[0058] Figure 4 This is a bar graph showing the changes in the average length of eye wrinkles after using the test substance;
[0059] Figure 5 This is a bar graph showing the changes in the average width of eye wrinkles after using the test substance;
[0060] Figure 6 This is a bar graph showing the changes in the average depth of eye wrinkles after using the test substance;
[0061] Figure 7 This is a bar graph showing the changes in the average width of nasolabial folds after the use of the test substance;
[0062] Figure 8 This is a bar graph showing the changes in the average depth of nasolabial folds after the use of the test substance;
[0063] Fig. 9 This is a bar graph showing the average width change of forehead wrinkles after using the test substance;
[0064] Fig.10 This is a bar graph showing the average depth changes of forehead wrinkles after using the test substance;
[0065] Fig.11 This is a bar graph showing the average depth changes of forehead wrinkles after using the test substance;
[0066] Fig.12 This is a bar graph of the changes in skin elasticity parameter R2 after the test substance is used;
[0067] Fig.13 This is a bar graph showing the changes in skin elasticity parameter F4 value after the test substance is used;
[0068] Fig.14 This is a bar graph showing the changes in skin glossiness after using the test substance;
[0069] Fig.15 It is a bar graph of the water content of the skin stratum corneum;
[0070] Fig.16 This is a bar graph showing the changes in transepidermal water loss at different time points after the use of the test substance;
[0071] Fig.17 This is a bar graph showing changes in skin hemoglobin after use of the test substance;
[0072] Fig.18 This is a bar graph of the changes in skin a* values after the use of the test substance;
[0073] Fig.19 A collection of photos of changes in local facial features before and after use for some subjects;
[0074] Fig. 20 A collection of photos of wrinkle improvement before and after use for some subjects;
[0075] Fig.21 A collection of photos showing wrinkle improvement after 4 hours of use for some subjects.
[0076] In the figure:
[0077] p value, "ns" indicates no statistical difference, p>0.05; "*" indicates significant difference, 0.01≤p<0.05; "**" indicates very significant difference, 0.001≤p<0.01; "***" indicates extremely significant difference, p<0.001. DETAILED DESCRIPTION
[0078] In order to make the technical solution, beneficial effects and significant improvements of the present invention more clear and comprehensive, the technical solution provided by the present invention will be clearly and completely described below through specific embodiments and their effect examples. Obviously, all the described embodiments are only partial embodiments of the present invention, rather than all embodiments;
[0079] Based on the embodiments and effect examples in the present invention, all other embodiments and effect examples obtained by ordinary technicians in this field without making any creative work are within the scope of protection of the present invention.
[0080] It should be noted that:
[0081] The terms "first", "second", etc. in the specification and claims of the present invention and the embodiments and effect examples of the present invention are only used to distinguish different objects, rather than to describe a specific order;
[0082] In addition, the term "comprises" and any variations thereof are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device that not only includes a series of listed steps or units, but also optionally includes unlisted steps or units, or optionally includes other steps or units inherent to these processes, methods, products or devices.
[0083] What needs to be understood is:
[0084] In the description of the embodiments of the present invention, some basic operating terms commonly used in the art are used, for example, "mixing", "stirring", "filtering", "heating", "cooling", etc. These terms should be understood in a broad sense and may be conventional operations performed by various conventional equipment and instruments used in the art, or may be program-controlled operations, unmanned automatic operations, etc. performed by the latest equipment. Unless otherwise clearly defined, ordinary technicians in this field should understand the specific meanings of the above terms in the present invention according to the specific circumstances, and adopt specific operating methods to achieve their operating purposes.
[0085] It should also be noted that:
[0086] The following specific embodiments may be combined with each other, and the same or similar concepts or processes therein may not be described in detail in some embodiments and their effect examples;
[0087] In addition, various raw materials and auxiliary materials, preservatives and other reagents, production equipment, facilities, etc. involved in the following specific embodiments and effect examples are all commercially available.
[0088] The technical solution of the present invention is described in detail below with specific embodiments and their effect examples.
[0089] Example
[0090] This embodiment provides an anti-wrinkle composition containing sodium DNA and RNA for rapid anti-wrinkle and long-lasting smoothness of human facial skin.
[0091] An anti-wrinkle composition comprising sodium DNA and RNA, comprising:
[0092] Polydeoxyribonucleotides and collagen as anti-wrinkle agents, ribonucleic acid as a neurotransmitter inhibitor, and antioxidants, moisturizers, thickeners, diluents, pH adjusters and preservatives that can be added to cosmetics.
[0093] Preferably, in the anti-wrinkle composition provided in this embodiment comprising sodium DNA and RNA:
[0094] The antioxidant is p-hydroxyacetophenone, the moisturizers are sodium hyaluronate, glycerin, butylene glycol and 1,2-pentanediol, the thickeners are sclerotium gum and carbomer, the diluent is water, the pH adjuster is arginine, and the preservatives are glyceryl caprylate, caprylhydroxamic acid and 1,3-propylene glycol.
[0095] Preferred:
[0096] 100 mL of the anti-wrinkle composition with sodium DNA and RNA provided in this embodiment contains:
[0097] Polydeoxyribonucleotide 0.50-0.52g, collagen 0.10-0.12g, ribonucleic acid 0.010-0.012g, p-hydroxyacetophenone 0.50-0.52g, sodium hyaluronate 0.05-0.06g, glycerol 6.0-6.2g, butylene glycol 4.0-4.2g, 1,2-pentanediol 3.0-3.2g, sclerotium gum 0.10-012g, carbomer 0.10-0.12g, arginine 0.10-0.12%, glyceryl caprylate, caprylhydroxamic acid and 1,3-propylene glycol totaling 0.30-0.32g, and the rest is water.
[0098] Further:
[0099] The anti-wrinkle composition containing sodium DNA and RNA provided in this embodiment is a clear purple to purple-red transparent liquid with a pH value of 6.5-7.5 and a relative density of 1.02-1.04 at 20°C.
[0100] Further:
[0101] The anti-wrinkle composition with sodium DNA and RNA provided in this embodiment is tested according to the provisions of Chapter 4 of the National Standard of the People's Republic of China "Technical Specifications for Safety of Cosmetics" (2015 Edition), and its mercury content is ≤1 mg / kg, its lead content is ≤10 mg / kg, its arsenic content is ≤2 mg / kg, and its cadmium content is ≤5 mg / kg.
[0102] Further:
[0103] The anti-wrinkle composition with sodium DNA and RNA provided in this embodiment is tested in accordance with the provisions of Chapter 5 of the National Standard of the People's Republic of China "Technical Specification for Safety of Cosmetics" (2015 Edition), and its total colony count is ≤1000CFU / g, its total mold and yeast count is ≤100CFU / g, and its thermotolerant coliform group, Staphylococcus aureus and Pseudomonas aeruginosa shall not be detected.
[0104] Furthermore, the anti-wrinkle composition provided in this embodiment having sodium DNA and RNA is prepared by the following method:
[0105] Put the diluent in a preparation pot, slowly sprinkle carbomer as a thickener, and pre-disperse sodium hyaluronate, glycerin, butylene glycol as a moisturizer and sclerotium gum as a thickener to prepare a uniformly dispersed mixture, then add the mixture to the preparation pot, stir and heat, then add 1,2-pentanediol as a moisturizer and an antioxidant, continue stirring until the materials in the preparation pot are uniform, then cool down for the first time, then add a pH adjuster to adjust the pH, cool down for the second time, then add a preservative, a neurotransmitter inhibitor, an anti-wrinkle agent and other materials as thickeners and moisturizers, continue stirring until uniform, let stand, and then filter with a sieve to obtain the product.
[0106] Preferred:
[0107] In the method for preparing the anti-wrinkle composition containing sodium DNA and RNA, the heating temperature is 70-75°C, the first cooling temperature range is 50-55°C, and the second cooling temperature range is below 40°C.
[0108] Preferred:
[0109] In the method for preparing the anti-wrinkle composition containing sodium DNA and RNA, the stirring speed is 5 to 50 r / min, and the filtration screen specification is 200 meshes.
[0110] Preferred:
[0111] In the method for preparing the anti-wrinkle composition containing sodium DNA and RNA, the preparation pot is a stainless steel steam heating pot with a stirring device.
[0112] From the above description, we can see that:
[0113] The anti-wrinkle composition with DNA sodium and RNA provided in this embodiment includes polydeoxyribonucleotides and collagen as anti-wrinkle agents, ribonucleic acid as a neurotransmitter inhibitor, and antioxidants, moisturizers, thickeners, diluents, pH adjusters and preservatives that are acceptable for addition to cosmetics, wherein:
[0114] Polydeoxyribonucleotides, namely DNA sodium (DNA-Na, PDRN), which is an anti-wrinkle agent, are a skin cell repair activator that can quickly activate the skin's inherent regeneration ability and activate collagen production;
[0115] Collagen, which is also an anti-wrinkle agent, can regulate the internal and external balance of fibroblasts, stimulate the production of collagen types I and III, support the epidermis to stretch the dermis, activate skin vitality in both directions, and have a good effect of delaying skin aging and enhancing skin elasticity.
[0116] As a neurotransmitter inhibitor, ribonucleic acid (RNA) can effectively inhibit the release of neurotransmitters and suppress expression lines.
[0117] Tests prove:
[0118] The anti-wrinkle composition provided in this embodiment, which is obtained by organically and exquisitely combining the anti-wrinkle agent, neurotransmitter inhibitor, antioxidant, moisturizer, thickener, diluent, pH adjuster and preservative, especially the sodium DNA and collagen as anti-wrinkle agents and RNA as neurotransmitter inhibitor, can quickly reduce wrinkles and keep the skin smooth after simply applying it to the human face, so that the user can restore a youthful and beautiful face.
[0119] Since the anti-wrinkle composition with sodium DNA and RNA provided in this embodiment has a clear grasp of the mechanism of wrinkle generation on human skin, and the formula is simple and clear, and the compatibility is appropriate and reasonable, the product is mild and soothing, and the effect is excellent. It is not only safe, mild and non-irritating, but also suitable for people with sensitive skin. It has obvious moisturizing, anti-wrinkle, and skin tightening effects, and also has soothing effects such as improving skin redness, itching, and burning sensations. It is simple to prepare and easy to use. Therefore, it has great promotion and application value.
[0120] To further help understand the technical effects that can be obtained by the technical solution of the anti-wrinkle composition containing sodium DNA and RNA provided in this embodiment, the above technical solution is further explained below through the preparation cases of the anti-wrinkle composition containing sodium DNA and RNA of 3 specific production batches listed in Table 1.
[0121] illustrate:
[0122] In Table 1, 240124F61, 240201F55, and 240226F60 are three batches of anti-wrinkle compositions containing sodium DNA (polydeoxyribonucleotide) and RNA (ribonucleic acid), respectively. "Content in 100 mL (g)" refers to the weight of the constituent substances contained in 100 mL of the anti-wrinkle composition containing sodium DNA and RNA.
[0123] Table 1
[0124]
[0125]
[0126] Polydeoxyribonucleotide (DNA sodium), salmon-derived PDRN, with a molecular weight of ≤1000kDa, was purchased from Ruijiming (Shandong) Biotechnology Co., Ltd., etc.; collagen, derived from human collagen, type I, type III or a combination of both, was purchased from Jiangsu Chuangjian Medical Technology Co., Ltd., etc.; ribonucleic acid (RNA), obtained through high-throughput screening by bioengineering AI design, was purchased from Shaanxi Harvard Biotechnology Co., Ltd., etc.; p-Hydroxyacetophenone and 1,2-pentanediol were from Dezhixin Flavors and Fragrances (Nantong) Co., Ltd., etc.; sodium hyaluronate was from Huaxi Biotechnology Co., Ltd., etc.; glycerol was from Tyco Brown Chemical (Zhangjiagang) Co., Ltd., etc.; carbomer was from Lubrizol Advanced Materials, Inc.; butanediol was from KH NeoChem CO., Ltd., etc.; 1,3-propanediol was from Primient Covation LLC, etc.; sclerotium gum was from ALBAN MULLERINTERNATIONAL, SAS, Cargill France SAS, etc.; arginine, from Japan Ajinomoto "L-arginine", etc.; glyceryl caprylate, purchased from INOLEX, lnc., etc.
[0127] To further help understand the technical effects that can be obtained by the technical solution provided in this embodiment, the anti-wrinkle composition containing sodium DNA and RNA is further described below through specific effect examples.
[0128] Effect Example 1: This effect example tests the physical and chemical indicators of the anti-wrinkle composition with DNA sodium and RNA obtained by the above technical solution to evaluate the safety of the product.
[0129] 1) The purple to purple transparent anti-wrinkle composition liquid containing sodium DNA and RNA of batch 240226F60 provided in the above embodiment was selected for physical and chemical index detection. The relevant detection items, detection methods, detection standards and detection results are listed in Table 1.1:
[0130] Table 1.1
[0131]
[0132] 2) The anti-wrinkle composition with sodium DNA and RNA, which is a purple to purple transparent liquid and has a batch number of 240201F55 provided in the above embodiment, was selected for physical and chemical index detection, wherein the inspection basis is the "Technical Specification for Safety of Cosmetics" (2015 edition), and the relevant microbial inspection results are shown in Table 1.2, and the relevant physical and chemical inspection results are shown in Table 1.3:
[0133] Table 1.2
[0134] Inspection items unit Test results Limits Total colony count CFU / g 150 ≤1000 Total mold and yeast count CFU / g <10 ≤100 Thermotolerant coliform bacteria / g Not detected Not to be detected Staphylococcus aureus / g Not detected Not to be detected Pseudomonas aeruginosa / g Not detected Not to be detected
[0135] Table 1.3
[0136]
[0137] From the data listed in Tables 1.1, 1.2 and 1.3, we can see that:
[0138] Microbiological and physical and chemical tests were carried out on the anti-wrinkle compositions containing sodium DNA and RNA from batches 240226F60 and 240201F55, and all indicators were in compliance with the requirements of the "Technical Specifications for Safety of Cosmetics" (2015 edition), a national standard of the People's Republic of China, and can meet the safety requirements for cosmetics.
[0139] It should be noted that:
[0140] Although Effect Example 1 only tested the anti-wrinkle composition containing sodium DNA and RNA of batches 240226F60 and 240201F55 for microbiological and physical and chemical items, and obtained the conclusion that it met the safety requirements of cosmetics, in fact, the same test on other batches of anti-wrinkle composition containing sodium DNA and RNA obtained by the technical solution provided in the above embodiment can also obtain basically the same test data, and can draw the same conclusion that it meets the safety requirements of cosmetics. However, for the sake of simplicity, this specification will not list more relevant test data.
[0141] Effect Example 2: This effect example conducts a questionnaire test on users of the anti-wrinkle composition with DNA sodium and RNA with batch number 240124F61 obtained by the above technical solution to evaluate the use effect of the product.
[0142] Note: The product described in this effect example is the purple to purple-red transparent anti-wrinkle composition liquid containing sodium DNA and RNA with batch number 240124F61 provided in the above embodiment.
[0143] Inspection items: Consumer questionnaire test on suitability for sensitive skin, anti-wrinkle, firming, soothing, glossiness and moisturizing effects.
[0144] Inspection basis: "Technical Specification for Safety of Cosmetics" (2015 Edition) (2015 Edition) Human Safety Trial Test, "Guidelines for Cosmetic Consumer Use Test-Questionnaire Evaluation" T / TDCA006-2022, Cosmetic Efficacy Evaluation (XⅢ)-Consumer Use Test [J], Surfactant Chemical Industry, 2021, 51(6): 6. "Facial Lactic Acid Stinging Method for Evaluation of Suitability of Skin Care Products for Sensitive Skin" T / SPMA006-2023.
[0145] 1. Materials and Methods
[0146] 1. Test substance: anti-wrinkle composition containing sodium DNA and RNA (Batch No.: 240124F61).
[0147] 2. Test purpose: A single-blind study was conducted to evaluate the changes in skin wrinkles, skin firmness, skin moisture, and skin redness of 30 subjects with sensitive skin and wrinkles before and after using the test samples through clinical evaluation and consumer use testing methods. The test samples' "suitability for sensitive skin", "anti-wrinkle", "firming", "soothing", "glossiness", and "moisturizing" effects were evaluated.
[0148] 3. Subjects: 30 subjects who met the test criteria were screened, and a total of 30 subjects actually completed the test, including 0 males and 30 females, aged 34 to 58 years old, with an average age of 47.9±6.1 years old. See Table 2.1 Subject Information Table for details.
[0149] Table 2.1 Subject information table
[0150]
[0151] 4. Subject requirements
[0152] 4.1. Inclusion criteria:
[0153] All 30 subjects completed the test, with an average age of 47.9±6.1 years. All subjects who completed the test met the following inclusion criteria, including:
[0154] The inclusion criteria for the subjects were as follows: volunteers aged 18 to 60 years old who met the test requirements were selected as subjects, and the subjects had positive lactic acid sting test or were determined to have sensitive skin by the sensitive skin questionnaire;
[0155] The following persons cannot be selected as subjects:
[0156] 1) Those who have used antihistamines in the past week or immunosuppressants in the past month;
[0157] 2) Those who have used any anti-inflammatory drugs in the tested area within the past two months;
[0158] 3) Subjects with inflammatory skin diseases that have not been clinically cured;
[0159] 4) Patients with insulin-dependent diabetes mellitus:
[0160] 5) Patients who are receiving treatment for asthma or other chronic respiratory diseases;
[0161] 6) Those who have received anti-cancer chemotherapy in the past 6 months;
[0162] 7) Patients with immunodeficiency or autoimmune diseases;
[0163] 8) Lactating or pregnant women;
[0164] 9) Bilateral mastectomy and bilateral axillary lymph node removal;
[0165] 10) Those whose facial scars, pigmentation, atrophy, port-wine stains or other blemishes may affect the test results;
[0166] 11) Participants in other clinical trials;
[0167] 12) People with highly sensitive constitution;
[0168] 13) Non-voluntary participants or those who are unable to complete the required content according to the test requirements.
[0169] 4.2. Subject Restrictions:
[0170] During the trial, the test area should use the test product provided by the testing organization, and stop using your own products with similar efficacy. Other daily product usage habits should remain unchanged.
[0171] 2. Testing Process
[0172] 1. Information registration (verification of identity information);
[0173] 2. Conduct a lactic acid sting test 7 to 3 days before the start of the long-term use test (safety evaluation) and screen those who test positive for lactic acid sting to participate in the test.
[0174] 3. On the day of the formal test, eligible subjects will be screened, signed the informed consent form and entered into the formal test.
[0175] First, the subjects were required to wash their faces and rest for 30 minutes in an environment with a temperature of 21±1°C and a relative humidity of 50±10%RH.
[0176] The product was then used correctly under the supervision of the experimenter, a single trial test of the product use test was completed, and the degree of burning, stinging, and itching discomfort of the subjects' skin after using the product for the first time was evaluated.
[0177] After the trial, the experimenter conducted a lactic acid sting test and recorded the subjects' lactic acid sting scores and total scores at 30s, 2, 5min and 5min respectively as the basic value of the lactic acid sting score.
[0178] After all process tests were completed, the subjects left the laboratory, used the products at home and were followed up in the second week.
[0179] 4. The subjects used the product at home. During the follow-up visit in the second week after using the product, they washed their faces as required and rested for 30 minutes in an environment with a temperature of 21±1℃ and a relative humidity of 50±10%RH. Laboratory experts evaluated the subjects' facial skin according to the human trial safety evaluation criteria and completed a consumer usage questionnaire survey.
[0180] After the above test, the experimenter conducted another lactic acid stinging test and recorded the lactic acid stinging score of the skin after 2 weeks of product use.
[0181] 5. Perform data analysis after the test.
[0182] 3. Test results
[0183] 1. Subjects’ facial feeling rating after using the product for the first time
[0184] The results of the subjects' facial sensation scores after using the product for the first time are shown in Table 2.2.
[0185] Table 2.2 Subjects' perception ratings after first use of the product
[0186]
[0187] Scoring criteria:
[0188] Burning score: 0: None; 1: Mild, occasionally felt; 2: Moderate, obvious burning, but tolerable; 3: Severe, very obvious burning, requiring cold water to relieve;
[0189] Stinging pain score: 0: None; 1: Mild, occasionally felt; 2: Moderate, obvious stinging pain, but tolerable; 3: Severe, very obvious stinging pain, requiring topical medication to relieve;
[0190] Itch score: 1 point (0 degree): basically no itching; 2 points (mild, degree I): slight itching, no need to scratch, can be relieved by stroking and patting, no secondary rash caused by scratching; 3 points (moderate, degree II): obvious itching, can't help scratching, mild secondary rash caused by scratching can be seen; 4 points and above (severe, degree III and extremely severe, degree IV): severe is severe itching, affecting sleep and work, obvious secondary rash caused by scratching can be seen locally, extremely severe is severe itching, affecting sleep and work, emotional distress, and secondary rashes are severe and numerous.
[0191] 2. Skin reactions during product use
[0192] The results of the laboratory staff’s clinical evaluation of adverse skin reactions during product use on test subjects are summarized in Table 2.3: Summary of the results of cosmetic sensitive skin suitability tests.
[0193] Table 2.3 Summary of cosmetics sensitive skin applicability test results
[0194]
[0195] Among them: The scoring criteria for adverse skin reactions are shown in Table 2.4
[0196] Table 2.4 Scoring criteria for adverse skin reactions
[0197] Rating Skin reactions 0 No response 1 Faint erythema 2 Erythema, diffuse rash, papules 3 Erythema, edema, papules, blisters 4 Erythema, edema, bullae
[0198] 3. Lactic acid stinging evaluation and subject self-assessment
[0199] 3.1. Lactic acid stinging evaluation
[0200] Before using the product and after 2 weeks of use, the testers conducted a lactic acid stinging test on 30 subjects, and evaluated the stinging of the test area at 30s, 2, 5min and 5min, calculated the total sensation score, and evaluated the improvement of skin irritation after using the product. The improvement scores of the subjects' stinging symptoms after using the product are shown in Table 2.5.
[0201] Table 2.5 Subjects' lactic acid sting test symptom improvement scores
[0202] Total pain score before use Total pain score after use 3.34±0.48 1.76±0.74
[0203] 3.2 Subjective evaluation of improvement in skin condition
[0204] Before using the product and 2 weeks after use, clinicians conducted clinical assessments on the symptoms of stinging, itching, burning, redness and dryness of the skin of 30 subjects, and evaluated the improvement in skin irritation after product use. The scores of clinical symptom improvement of the subjects after product use are shown in Table 2.6 below.
[0205] Table 2.6 Subjects’ Skin Clinical Symptom Assessment Table [Total, (minimum, maximum)]
[0206]
[0207]
[0208] Note: The scoring standard is 0 = no reaction; 1 = mild; 2 = moderate; 3 = severe.
[0209] 4. Results of the questionnaire used by the test subjects
[0210] After using the product, the subjects evaluated the product's "suitability for sensitive skin", moisturizing, soothing, firming, and anti-wrinkle effects through a consumer questionnaire. The following is the survey content of the questionnaire.
[0211] 4.1. The product is mild (non-irritating) and suitable for sensitive skin
[0212] During the use of the product, all subjects had no adverse reactions or discomfort. The results are shown in Table 2.7 below.
[0213] Table 2.7 Survey results of subjects on products suitable for sensitive skin
[0214]
[0215] 4.2. Skin feel after using the product
[0216] After the subjects finished using the product, they were asked to fill in their overall feelings about the product and their skin satisfaction after using the product. The results are shown in Table 2.8.
[0217] Table 2.8 Survey results on skin feel after using the product
[0218] serial number question agree p-value 1 The product has a refreshing and non-sticky texture 100% <0.001 2 Easy to absorb after using the product 100% <0.001
[0219] 4.3. Evaluation of product moisturizing and glossiness
[0220] A consumer questionnaire survey was conducted after using the product for 2 weeks, asking the subjects to evaluate the moisturizing and glossing effects of the product based on their experience using the product. The results are shown in Table 2.9.
[0221] Table 2.9 Survey results of subjects on product moisturizing and glossing efficacy claims
[0222]
[0223]
[0224] 4.4. Evaluation of product anti-wrinkle efficacy
[0225] The subjects were asked to complete a consumer questionnaire survey after using the product for 2 weeks, and evaluate the anti-wrinkle efficacy of the product in improving skin fine lines and texture based on their experience using the product. The results are shown in Table 2.10.
[0226] Table 2.10 Survey results of subjects on product anti-wrinkle claims
[0227]
[0228] 4.5. Evaluation of product firming efficacy
[0229] The consumer questionnaire survey was conducted after the subjects had used the product for 2 weeks, asking the subjects to evaluate the product's skin tightening efficacy based on their experience using the product. The results are shown in Table 2.11.
[0230] Table 2.11 Survey results of subjects on product firming claims
[0231]
[0232] 4.6. Evaluation of product soothing effect
[0233] The subjects were asked to complete a consumer questionnaire survey 2 weeks after using the product, and the subjects were asked to evaluate the soothing effect of the product based on their experience using the product. The results are shown in Table 2.12 Survey results on the subjects' claims of the product's soothing and firming effects.
[0234] Table 2.12 Survey results of subjects on product claims of soothing and firming effects
[0235]
[0236] IV. Inspection conclusion:
[0237] The potential for causing adverse reactions to human skin was evaluated by observing 30 subjects with sensitive skin after continuous use of the test samples for 2 weeks under normal conditions.
[0238] The clinical evaluation results of dermatologists showed that none of the 30 subjects experienced any adverse reactions after use, and the self-evaluation results of the subjects showed that they did not feel any discomfort during or after use.
[0239] The test results show that the anti-wrinkle composition containing sodium DNA and RNA with batch number 240124F61 has high safety, the product is "mild (non-irritating)", and meets the requirements of "suitable for sensitive skin".
[0240] After continuously using the test sample for 2 weeks under normal conditions, through this consumer questionnaire test, in terms of the texture experience of product use, 100% of the subjects believed that "when using the product, it is refreshing and non-greasy", and 100% of the subjects believed that "the product is easily absorbed". After 2 weeks of product use, based on the fact that 100% of the subjects believed that "after using the product, the skin does not feel dry or tight and feels more moisturized", 96.7% of the subjects believed that "after using the product, the skin feels more hydrated and moisturized", 93.3% of the subjects believed that "after using the product, the skin feels stronger", 90.0% of the subjects believed that "after using the product, the skin looks more radiant", 90.0% of the subjects believed that "after using the product, the skin feels softer", 93.3% of the subjects believed that "after using the product, the skin looks more hydrated and translucent", and the results showed significant differences, indicating that the skin glossiness increased after using this product. Therefore, it can be determined that it has the "moisturizing" effect.
[0241] After 2 weeks of product use, based on the fact that 93.3% of the subjects believed that "after using the product, the skin feels smoother and more delicate", 86.7% of the subjects believed that "after using the product, the skin feels more plump and full", 86.7% of the subjects believed that "after using the product, it has the effect of improving skin roughness", and 86.7% of the subjects believed that "after using the product, it has the effect of reducing fine lines and wrinkles on the face", 90.0% of the subjects believed that "after using the product, it has the effect of improving facial wrinkles", 83.3% of the subjects believed that "after using the product, it has the effect of improving crow's feet", 83.3% of the subjects believed that "after using the product, it has the effect of improving wrinkles under the eyes", 90.0% of the subjects believed that "after using the product, it has the effect of improving forehead fine lines", 83.3% of the subjects believed that "after using the product, it has the effect of improving forehead wrinkles", 83.3% of the subjects believed that "after using the product, it has the effect of improving nasolabial folds", 86.7% of the subjects believed that "after using the product, it has the effect of improving glabellar lines", 90.0% of the subjects believed that "after using the product, it has the effect of improving marionette lines (corners of the mouth lines)", 93.3% of the subjects believed that "after using the product, it has the effect of improving nose wrinkles (nasal bridge lines)", and the results showed significant differences. Therefore, it can be determined that it has the "anti-wrinkle" effect.
[0242] After 2 weeks of product use, based on the fact that 93.3% of the subjects believed that "after using the product, the skin feels firmer", 90.0% of the subjects believed that "after using the product, the skin feels more elastic", 93.3% of the subjects believed that "after using the product, it has the effect of improving skin laxity", and the results showed significant differences. Therefore, it can be determined that it has the "firming" effect.
[0243] After using the product for 2 weeks, 90.0% of the subjects believed that "after using the product, skin redness is effectively improved", 93.3% of the subjects believed that "after using the product, skin itching is effectively improved", and 93.3% of the subjects believed that "after using the product, skin burning sensation is effectively improved", and the results showed significant differences. Therefore, it can be determined that it has a "soothing" effect.
[0244] Effect Example 3: This effect example further evaluates the product safety by conducting a human skin patch test on the anti-wrinkle composition containing sodium DNA and RNA with batch number 240124F61 obtained in the above example.
[0245] Inspection item: human skin patch test.
[0246] Inspection basis: "Technical Specification for Safety of Cosmetics" (2015 edition) human skin patch test.
[0247] 1. Materials and Methods
[0248] 1. Test substance: the purple to purple-red transparent anti-wrinkle composition containing sodium DNA and RNA with batch number 240124F61 obtained in the above example.
[0249] 2. Negative control: blank filter paper control.
[0250] 3. Subjects: A total of 30 subjects, including 7 males and 23 females, aged 19 to 45 years old, with an average age of 37.0 ± 7.1 years old, who met the voluntary inclusion criteria.
[0251] 4. Patch test method: Using the closed patch test method, place about 0.025 mL of the test substance in the patch tester and apply it to the curved side of the subject's forearm with a low-allergenic tape. Remove the test substance after 24 hours and observe the skin reaction at 0.5, 24, and 48 hours after removal. Record the results according to the skin reaction grading standard in human skin patch test in Chapter 7 of "Technical Specifications for Safety of Cosmetics" (2015 edition).
[0252] 2. Test results
[0253] The skin reactions of the 30 subjects at different observation times are shown in Tables 3.1 and 3.2.
[0254] Table 3.1 Skin reactions of 30 subjects at different observation times
[0255]
[0256]
[0257] Table 3.2 Summary of cosmetics human skin patch test results
[0258]
[0259] Note: Skin reaction rating:
[0260] 0 = negative reaction;
[0261] 1 = questionable reaction, only slight erythema;
[0262] 2 = weak positive reaction (erythema reaction); erythema, infiltration, edema, and papules may be present;
[0263] 3 = Strong positive reaction (herpes reaction); erythema, infiltration, edema, papules, herpes; the reaction may extend beyond the test area;
[0264] 4 = Very strong positive reaction (confluent herpes reaction); obvious erythema, severe infiltration, edema, confluent herpes; reaction exceeds the test area.
[0265] 3. Inspection conclusion:
[0266] The results of the human skin patch test showed that no adverse skin reactions occurred in 30 people, indicating that the anti-wrinkle composition containing sodium DNA and RNA with batch number 240124F61 obtained by the technical solution provided in the above embodiment is safe for human skin.
[0267] Effect Example 4: This effect example evaluates the anti-wrinkle composition with sodium DNA and RNA of batch number 240124F61 provided in the above example on the face of the test subject to evaluate its sensitive skin applicability, moisturizing, firming, anti-wrinkle, repairing and glossiness functions.
[0268] 1. Methods and Materials
[0269] 1. Test method:
[0270] 1.1. With reference to the "Human Evaluation Method for Cosmetic Repair Efficacy T / GDCA009-2022" and the "Test Method for Cosmetic Anti-wrinkle, Firming, Moisturizing, Oil Control, Repair, Nourishing, and Soothing Efficacy T / CAB 0152-2022", the moisturizing and repairing effects of the product are evaluated by evaluating the main parameter of transepidermal water loss rate before and after the subjects use the test samples, as well as the improvement of the secondary parameters of skin hemoglobin and skin moisture content.
[0271] 1.2. Refer to the "Test Methods for Seven Efficacy of Cosmetics: Anti-wrinkle, Firming, Moisturizing, Oil Control, Repairing, Nourishing, and Soothing T / CAB0152-2022" and "Test Methods for Anti-wrinkle Efficacy of Cosmetics T / ZHCA006-2019", and evaluate the changes in the average length, average width, and average depth of the subjects' eye wrinkles, forehead wrinkles, and nasolabial folds before and after using the test samples through instruments, as well as clinically evaluate the changes in the subjects' wrinkle grading to evaluate the anti-wrinkle efficacy of the product.
[0272] 1.3. Refer to the "Test Methods for Seven Efficacy of Cosmetics: Anti-wrinkle, Firming, Moisturizing, Oil Control, Repairing, Nourishing, and Soothing T / CAB0152-2022" and "Test Methods for Firming Efficacy of Cosmetics T / TDCA003-2021" to evaluate the changes in firming parameters before and after the subjects use the test samples through instruments to evaluate the firming efficacy of the product.
[0273] 2. Test substance: the purple to purple-red transparent anti-wrinkle composition containing sodium DNA and RNA with batch number 240124F61 provided in the above example.
[0274] 3. Subjects: 30 female subjects who met the test conditions were screened, of which 0 withdrew from the test due to personal reasons. A total of 30 subjects actually completed the test, ranging in age from 36 to 60 years old, with an average age of 49.7±8.0 years old. The subject information is shown in Table 4.1.
[0275] Table 4.1 Subject information table
[0276]
[0277] 4. Subject requirements
[0278] 4.1. Inclusion criteria: All 30 subjects completed the test, with an average age of 49.7±8.0 years. All subjects who completed the test met the following inclusion criteria.
[0279] Subject inclusion criteria:
[0280] 1) Aged between 35 and 60, healthy, female;
[0281] 2) The subjects do not have severe chronic wasting diseases (such as asthma, diabetes, etc.);
[0282] 3) Able to cooperate with researchers well according to the requirements of the experimental protocol;
[0283] 4) Those who have not participated in other clinical trials in the past month;
[0284] 5) Not currently participating in other clinical testing projects;
[0285] 6) The subject's face is sagging and there are obvious wrinkles in the tested area.
[0286] Those who have the following conditions cannot be selected as subjects:
[0287] 1) Pregnant or breastfeeding women
[0288] 2) Those who have used antihistamines in the past week or immunosuppressants in the past month;
[0289] 3) Those who have used any anti-inflammatory drugs in the tested area within the past two months;
[0290] 4) People with facial eczema, severe seborrheic dermatitis or folliculitis;
[0291] 5) The test area has large birthmarks, scratches, white spots, pigmented moles, keloids and other skin manifestations that affect the test;
[0292] 6) received a vaccination in the past month or planned to receive a vaccination during the study period;
[0293] 7) Patients with insulin-dependent diabetes or immunodeficiency or autoimmune diseases;
[0294] 8) Those who cannot cooperate with the experiment.
[0295] The subjects should also pay attention to the following:
[0296] 1) Subjects are prohibited from using other types of anti-wrinkle cosmetics during the test period. Other cosmetics such as lotion, moisturizing lotion or other care products can be used as usual;
[0297] 2) Subjects are prohibited from taking preparations that may affect the test results (such as anti-inflammatory drugs, cold medicines, injections);
[0298] 3) It is prohibited to perform cosmetic procedures or treatments that may affect the test results, such as laser spot removal and skin rejuvenation, during the test period;
[0299] 4) Subjects were not allowed to change any facial products or skin care habits during the test period.
[0300] 4.2. Subject Restrictions:
[0301] During the test, the test parts should use the test products provided by the test agency, and no other products with the same efficacy or that may affect the test results should be used. The usage habits of other daily necessities such as soap and shower gel should be kept consistent.
[0302] 2. Evaluation Instruments
[0303] 1. Vapometer, test parameters: TEWL value of the skin. A decrease in this value indicates that the skin barrier function has improved.
[0304] 2. Skin color measurement and tester SKINCOLORCATCH, test parameters: a* represents the red and green color of the object: positive value represents red, negative value represents green, and a smaller a* indicates a weakening of red.
[0305] 3. German CK company skin testing instrument MPA580 - skin moisture test probe Corneometer, test parameters: skin stratum corneum moisture content Corneometer value (CU), the higher the value, the higher the moisture content of the skin stratum corneum.
[0306] 4. German CK company skin testing instrument MPA580 - Skin elasticity tester Cutometer, test parameters: skin firmness parameter F4, the smaller the value, the tighter the skin.
[0307] 5. Gloss tester SKINGLOSSMETER, test parameters: skin gloss value, the higher the value, the better the skin gloss.
[0308] 6. German CK company's skin testing instrument MPA580 - skin melanin and hemoglobin test probe MX18, test parameter: hemoglobin, a decrease in this value indicates that skin redness has improved.
[0309] 7. Antera3D, test parameters: skin wrinkle length, average width, average depth, etc. The reduction of these values indicates that skin wrinkles have been improved.
[0310] 8. VISIA-CR collects facial images of subjects.
[0311] 3. Testing Process
[0312] 1. Information registration (verification of identity information).
[0313] 2. Screen subjects who meet the requirements and sign the informed consent form. Screen subjects with sensitive skin through questionnaires. Subjects who feel that their skin barrier function is damaged due to dryness, desquamation, redness, obvious wrinkles at the corners of the eyes, and nasolabial folds and forehead wrinkles are selected for the test.
[0314] 3. Subjects who meet the requirements will enter the trial. Before the test, they will wash their faces with a unified cleansing product and then equilibrate in an environment with an ambient temperature of 20-22°C and a relative humidity of 40-60% for at least 20 minutes. Then, full-face images of the subjects will be collected, and wrinkles at the corners of the eyes, forehead wrinkles, and nasolabial folds will be photographed. The subjects will then be tested for transepidermal water loss rate, skin moisture content, skin hemoglobin, as well as skin firmness parameters and initial skin glossiness.
[0315] 4. After the initial value test is completed, the laboratory technician will distribute test samples to the enrolled subjects and instruct the subjects to use the product as required.
[0316] After 4 hours, images of the subjects' eye wrinkles were collected again to compare the improvement of eye wrinkles after 4 hours of use.
[0317] The first day's testing process was completed, and the subjects took the product away and used it at home. During the entire testing period, the subjects strictly followed the usage requirements and used the product correctly and continuously.
[0318] 5. The subjects used the product at home and returned for follow-up visits in the 1st, 2nd and 4th weeks to collect full-face images, take photos of eye wrinkles, forehead wrinkles and nasolabial folds, and re-test the transepidermal water loss rate, skin moisture content, skin hemoglobin, skin gloss and skin firmness.
[0319] 6. Perform data analysis after the test is completed.
[0320] 4. Test results
[0321] 1. Results of improvement of eye wrinkles after 4 hours of use of the test substance
[0322] On the test day, 4 hours after using the product, wrinkles in a fixed selected area around the subject's eyes were analyzed.
[0323] The test results are as follows:
[0324] 1) Table 4.2 Results of the length, average width and average depth of eye wrinkles of the test subject 4 hours after using the product;
[0325] 2) Table 4.3 The difference results of eye wrinkles 4 hours after the test substance was used;
[0326] as well as:
[0327] Figure 1 Bar graph showing the change in average length of eye wrinkles 4 hours after the test substance was used;
[0328] Figure 2 Bar graph showing the change in average width of eye wrinkles 4 hours after the test substance was used;
[0329] Figure 3 Bar graph showing the change in average depth of eye wrinkles 4 hours after using the test substance.
[0330] Table 4.2 Results of the length, average width and average depth of eye wrinkles 4 hours after the test product was used
[0331]
[0332] Table 4.3 Results of difference in eye wrinkles 4 hours after using the test substance
[0333] Evaluation indicators 4 hours improvement 4-hour improvement rate (%) Average length of eye wrinkles (mm) <![CDATA[-6.17 *** ]]> -20.54 Average width of eye wrinkles (mm) <![CDATA[-0.14 *** ]]> -18.68 Average depth of eye wrinkles (mm) <![CDATA[-0.0053 *** ]]> -17.49
[0334] 2. Wrinkle improvement results at different time points after using the test substance
[0335] 2.1. Results of improvement of eye corner wrinkles at different time points after using the test substance
[0336] After using the product for 1, 2, and 4 weeks, the wrinkles in the fixed selected area around the corners of the eyes of the subjects were analyzed. The results showed that the wrinkles in the corners of the eyes of the subjects before and after using the product were significantly improved. The results are shown in:
[0337] Table 4.4 Results of the length, average width and average depth of eye wrinkles at different time points after the use of the test substance;
[0338] Table 4.5 The difference results of eye wrinkles at different time points after using the test substances;
[0339] as well as:
[0340] Figure 4 A bar graph showing the changes in the average length of eye wrinkles after the test substance was used;
[0341] Figure 5 Histogram of changes in average width of eye wrinkles after using the test substance;
[0342] Figure 6 Bar graph showing the changes in the average depth of eye wrinkles after using the test substance.
[0343] Table 4.4 Results of the length, average width and average depth of eye wrinkles at different time points after using the test substance
[0344]
[0345] Table 4.5 Difference results of eye wrinkles at different time points after using the test substance
[0346]
[0347]
[0348] 2.2 Results of improvement of nasolabial folds at different time points after use of the test substance
[0349] After using the product for 1, 2, and 4 weeks, the wrinkles in the fixed area of the subjects' facial nasolabial folds were analyzed. The results showed that the nasolabial folds in the selected area were significantly improved before and after the use of the product. The results are shown in:
[0350] Table 4.6 Results of average width and average depth of nasolabial folds after use of the test substance;
[0351] Table 4.7 Results of nasolabial fold difference at different time points after the use of the test substance;
[0352] as well as:
[0353] Figure 7 The bar graph of the changes in the average width of the nasolabial folds after the use of the test substance;
[0354] Figure 8 Bar graph showing the changes in the average depth of nasolabial folds after using the test substance.
[0355] Table 4.6 Results of average width and depth of nasolabial folds after use of the test substance
[0356]
[0357] Table 4.7 Results of nasolabial fold difference at different time points after using the test substance
[0358]
[0359] 2.3. Improvement results of forehead wrinkles at different time points after using the test substance
[0360] After using the product for 1, 2, and 4 weeks, the wrinkles in a fixed area of the subjects' foreheads were analyzed. The results showed that the forehead wrinkles in the selected area were significantly improved before and after using the product. The results are shown in:
[0361] Table 4.6 Results of average width and average depth of nasolabial folds after use of the test substance;
[0362] Table 4.7 Results of nasolabial fold difference at different time points after the use of the test substance;
[0363] as well as:
[0364] Fig. 9 Histogram of the average width change of forehead wrinkles after using the test substance;
[0365] Fig.10 Histogram of the average depth change of forehead wrinkles after using the test substance;
[0366] Fig.11 Bar graph showing the average depth changes of forehead wrinkles after using the test substance.
[0367] Table 4.8 Results of average width and depth of forehead wrinkles after using the test substance
[0368]
[0369] Table 4.9 Difference results of forehead wrinkles at different time points after using the test substance
[0370]
[0371] 3. Elasticity and firmness results at different time points after using the test substance
[0372] 3.1. Elasticity parameter R2 results
[0373] After using the product for 1, 2, and 4 weeks, the skin elasticity of the subjects' cheeks was analyzed. The results showed that the subjects' facial elasticity parameter R2 was significantly increased compared to before use. The results are shown in:
[0374] Table 4.10 Elasticity parameter R2 results at different time points after the test article is used;
[0375] Table 4.11 Results of R2 difference of elastic parameters at different time points after the test objects were used;
[0376] as well as:
[0377] Fig.12 Bar graph of changes in skin elasticity parameter R2 after use of the test substance.
[0378] Table 4.10 Elasticity parameter R2 results at different time points after use of the test article
[0379] parameter Base Value Week 1 Week 2 Week 4 Mean ± SD 0.46±0.096 0.47±0.073 0.51±0.074 0.54±0.052 Maximum 0.67 0.61 0.70 0.69 Minimum 0.29 0.36 0.41 0.46 median 0.45 0.48 0.51 0.55 Normality test p-value >0.05 >0.05 <0.05 >0.05 Significant p-value / >0.05 <0.05 <0.001 Significance / ns * ***
[0380] Table 4.11 Elastic parameter R2 difference results at different time points after the test object is used
[0381]
[0382] 3.2. Compact parameter F4 results
[0383] After using the product for 1, 2, and 4 weeks, the skin firmness of the subjects' cheeks was analyzed. The results showed that the facial firmness parameter F4 of the subjects was significantly reduced compared with before use. The results are shown in Tables 11 to 12. Fig.13 The results are:
[0384] Table 4.12 Results of the firming parameter F4 at different time points after the use of the test substance;
[0385] Table 4.13 Results of the difference in the compaction parameter F4 at different time points after the use of the test substance;
[0386] as well as:
[0387] Fig.13 Bar graph of changes in skin elasticity parameter F4 value after use of the test substance.
[0388] Table 412 Results of firming parameter F4 at different time points after use of the test substance
[0389] parameter Base Value Week 1 Week 2 Week 4 Mean ± SD 2.48±0.48 2.31±0.47 2.06±0.38 1.89±0.42 Maximum 3.42 3.49 2.88 2.56 Minimum 1.62 1.50 1.52 1.18 median 2.45 2.15 1.91 1.82 Normality test p-value >0.05 <0.05 <0.05 >0.05 Significant p-value / >0.05 <0.001 <0.001 Significance / ns *** ***
[0390] Table 4.13 The difference results of the compaction parameter F4 at different time points after the test substance was used
[0391]
[0392] 3.3. Gloss results of the test article at different time points after use
[0393] After using the product for 1, 2, and 4 weeks, the glossiness of the subjects' cheeks was analyzed. The results showed that the glossiness of the subjects' faces was significantly higher than before use. The results are as follows:
[0394] Table 4.14 Gloss results of the test objects at different time points after use;
[0395] Table 4.15 Gloss difference results of the test objects at different time points after use;
[0396] as well as:
[0397] Fig.14 Bar graph showing changes in skin glossiness after use of the test substance.
[0398] Table 4.14 Gloss results of the test objects at different time points after use
[0399] parameter Base Value Week 1 Week 2 Week 4 Mean ± SD 71.56±7.82 74.09±8.08 76.17±8.10 83.06±11.23 Maximum 87.50 89.50 91.25 110.75 Minimum 56.50 58.00 53.75 58.25 median 71.75 72.75 75.50 83.63 Normality test p-value >0.05 >0.05 >0.05 >0.05 Significant p-value / >0.05 <0.01 <0.001 Significance / ns ** ***
[0400] Table 4.15 Gloss difference results of the test objects at different time points after use
[0401]
[0402] 4. Results of skin moisture content at different time points after using the test substance
[0403] After using the product for 1, 2, and 4 weeks, the moisture content of the skin on the cheeks of the subjects was analyzed. The results showed that the moisture content of the stratum corneum on the faces of the subjects increased significantly compared with before use. The results are shown in:
[0404] Table 4.16 Results of water content of the stratum corneum of the skin at different time points after use of the test substance;
[0405] Table 4.17 Results of moisture difference of skin stratum corneum at different time points after using the test substance;
[0406] as well as:
[0407] Fig.15 Histogram of water content in the stratum corneum of the skin.
[0408] Table 4.16 Results of water content of the stratum corneum at different time points after use of the test substance
[0409]
[0410]
[0411] Table 4.17 Results of moisture difference of skin stratum corneum at different time points after using the test substance
[0412]
[0413] 5. After using the product for 1, 2 and 4 weeks, the transepidermal water loss rate of the subjects' cheeks was analyzed. The results showed that the TEWL value (g / m2 / h) of the subjects' faces was significantly lower than before use. The results are shown in:
[0414] Table 4.18 Results of transepidermal water loss TEWL values at different time points after use of the test substance;
[0415] Table 4.19 Difference results of transepidermal water loss TEWL at different time points after use of the test substance;
[0416] as well as:
[0417] Fig.16 Bar graph showing changes in transepidermal water loss at different time points after use of the test substance.
[0418] Table 4.18 Results of TEWL values at different time points after use of the test substance
[0419] parameter Base Value Week 1 Week 2 Week 4 Mean ± SD 13.37±3.93 13.28±3.65 12.17±2.55 11.15±2.58 Maximum 20.63 21.35 17.05 16.85 Minimum 8.28 7.93 7.33 6.50 median 12.50 12.68 12.06 10.65 Normality test p-value <0.05 >0.05 >0.05 >0.05 Significant p-value / >0.05 <0.05 <0.001 Significance / ns * ***
[0420] Table 4.19 Difference results of transepidermal water loss rate TEWL at different time points after use of the test substance
[0421]
[0422] 6. Skin hemoglobin results at different time points after use of the test substance
[0423] After using the product for 1, 2, and 4 weeks, the skin moisture on the cheeks of the subjects was analyzed. The results showed that the hemoglobin level in the facial skin of the subjects was significantly lower than before use. The results are as follows:
[0424] Table 4.20 Skin hemoglobin results at different time points after use of the test substance;
[0425] Table 4.21 Results of skin hemoglobin difference at different time points after the use of the test substance;
[0426] as well as:
[0427] Fig.17 Bar graph showing changes in skin hemoglobin after use of the test substance.
[0428] Table 4.20 Skin hemoglobin results at different time points after use of the test substance
[0429] parameter Base Value Week 1 Week 2 Week 4 Mean ± SD 307.00±37.35 298.18±44.42 283.66±46.39 276.06±41.87 Maximum 371.00 377.00 371.33 359.00 Minimum 240.00 227.00 183.17 181.33 median 308.17 286.19 281.33 271.83 Normality test p-value >0.05 >0.05 >0.05 >0.05 Significant p-value / >0.05 <0.001 <0.001 Significance / ns *** ***
[0430] Table 4.21 Skin hemoglobin difference results at different time points after using the test substance
[0431]
[0432] 7. a* value results at different time points after use of the test substance
[0433] After using the product for 1, 2, and 4 weeks, the skin moisture on the cheeks of the subjects was analyzed. The results showed that the a* value of the subjects' facial skin was significantly lower than before use. The results are shown in:
[0434] Table 4.22 a* value results at different time points after the use of the test substance;
[0435] Table 4.23 Difference results of a* values at different time points after the use of the test substance;
[0436] as well as:
[0437] Fig.18 Histogram of changes in skin a* values after use of the test substance.
[0438] Table 4.22 a* value results at different time points after use of the test substance
[0439] parameter Base Value Week 1 Week 2 Week 4 Mean ± SD 12.06±2.04 11.82±1.87 10.97±1.67 10.38±1.70 Maximum 15.25 16.75 14.50 14.50 Minimum 7.50 7.00 7.75 6.00 median 11.38 12.00 10.88 10.25 Normality test p-value >0.05 >0.05 >0.05 >0.05 Significant p-value / >0.05 <0.01 <0.001 Significance / ns ** ***
[0440] Table 4.23 Difference results of a* values at different time points after use of the test substance
[0441]
[0442]
[0443] 5. Results of the questionnaire on consumer use of the subjects
[0444] After using the product, the subjects evaluated the product's "suitability for sensitive skin", moisturizing, soothing, firming, and anti-wrinkle effects through a consumer questionnaire. The following is the survey content of the questionnaire.
[0445] 1. The product is mild (non-irritating) and suitable for sensitive skin
[0446] During the use of the product, all subjects had no adverse reactions or discomfort. The results are shown in Table 4.24 Survey results of subjects on the product "suitability for sensitive skin".
[0447] Table 4.24 Survey results of subjects on products “suitable for sensitive skin”
[0448]
[0449] 2. Skin feel after using the product
[0450] After the subjects have finished using the product, they are asked to fill in their overall feelings about the product and their satisfaction with their skin after using the product. The results are shown in Table 4.25 Survey results on skin feel experience after using the product.
[0451] Table 4.25 Survey results on skin feel after using the product
[0452] serial number question agree p-value 1 The product has a refreshing and non-sticky texture 100% <0.001 2 Easy to absorb after using the product 100% <0.001
[0453] 3. Evaluation of product moisturizing and glossiness
[0454] The subjects were asked to evaluate the moisturizing and glossing effects of the product based on their experience using the product in a consumer questionnaire survey after using the product for 4 weeks. The results are shown in Table 4.26 Survey results on the subjects' moisturizing and glossing effect claims of the product.
[0455] Table 4.26 Survey results of subjects on product moisturizing and glossing efficacy claims
[0456]
[0457] 4. Evaluation of the anti-wrinkle effect of the product
[0458] The subjects were asked to complete a consumer questionnaire survey after using the product for 4 weeks, and evaluate the anti-wrinkle efficacy of the product in improving skin fine lines and texture based on their experience using the product. The results are shown in Table 4.27 Survey results on subjects’ claims of anti-wrinkle efficacy of the product.
[0459] Table 4.27 Survey results of subjects on product anti-wrinkle claims
[0460]
[0461] 5. Evaluation of product firming effect
[0462] The subjects were asked to evaluate the skin tightening efficacy of the product based on their experience using the product in a consumer questionnaire survey after using the product for 4 weeks. The results are shown in Table 4.28 Survey results on subjects’ claims of the product’s skin tightening efficacy.
[0463] Table 4.28 Survey results of subjects on product firming claims
[0464]
[0465] 6. Evaluation of product soothing effect
[0466] The subjects were asked to complete a consumer questionnaire survey after using the product for 4 weeks, and the subjects were asked to evaluate the soothing effect of the product based on their experience using the product. The results are shown in Table 4.29. Survey results on the subjects' claims of the product's soothing and firming effects.
[0467] Table 4.29 Survey results of subjects on product soothing and firming efficacy claims
[0468]
[0469] 6. Results Analysis
[0470] from Fig.19 A collection of photos of changes in local facial features of some subjects before and after use, Fig. 20 Photo gallery of wrinkle improvement of some subjects before and after use, Fig.21 The following evaluation results were obtained from the photo collection of wrinkle improvement of some subjects after 4 hours of use and the above observations of the subjects:
[0471] By observing 30 subjects aged 27 to 60 years old, the potential possibility of the test sample causing adverse reactions to human skin was evaluated under normal conditions and continuous use for 4 weeks. The self-evaluation results of the subjects showed that no discomfort was felt during and after use. The test results show that the embodiment has a high safety, and it can be determined that the anti-wrinkle composition with sodium DNA and RNA provided in this embodiment is "mild (non-irritating);
[0472] After the subjects used the product for 4 hours, the length of the wrinkles at the corners of the eyes decreased by 20.54% (p<0.05), which was significantly different from before use. The average width of the wrinkles at the corners of the eyes decreased by 18.68% (p<0.05), which was significantly different from before use. The average depth of the wrinkles at the corners of the eyes decreased by 17.49% (p<0.05), which was significantly different from before use.
[0473] After the subjects used the product for 1 week, the length of the wrinkles at the corners of the eyes decreased by 13.33% (p<0.05) compared with before use, which was significantly different from before use. The average width of the wrinkles at the corners of the eyes decreased by 17.87% (p<0.05), which was significantly different from before use. The average depth of the wrinkles at the corners of the eyes decreased by 14.58% (p<0.05), which was significantly different from before use. The average width of the nasolabial folds decreased by 10.51% (p<0.05), which was significantly different from before use; the average depth of the nasolabial folds decreased by 11.97% (p<0.05), which was significantly different from before use. The average width of the forehead wrinkles decreased by 13.76% (p<0.05), which was significantly different from before use; the average depth of the forehead wrinkles decreased by 14.19% (p<0.05), which was significantly different from before use.
[0474] After the subjects used the product for 2 weeks, the length of the wrinkles at the corners of the eyes decreased by 17.55% (p<0.05), which was significantly different from before use, and the average width of the wrinkles at the corners of the eyes decreased by 15.72% (p<0.05), which was significantly different from before use. The average depth of the wrinkles at the corners of the eyes decreased by 16.17% (p<0.05), which was significantly different from before use; the average width of the nasolabial folds decreased by 13.03% (p<0.05), which was significantly different from before use. The average depth of the nasolabial folds decreased by 17.16% (p<0.05), which was significantly different from before use; the average width of the forehead wrinkles decreased by 17.66% (p<0.05), which was significantly different from before use, and the average depth of the forehead wrinkles decreased by 15.64% (p<0.05), which was significantly different from before use;
[0475] After the subjects used the product for 4 weeks, the length of the wrinkles at the corners of the eyes decreased by 25.61% (p<0.05) compared with before use, which was significantly different from before use. The average width of the wrinkles at the corners of the eyes decreased by 17.71% (p<0.05), which was significantly different from before use. The average depth of the wrinkles at the corners of the eyes decreased by 21.72% (p<0.05), which was significantly different from before use; the average width of the nasolabial folds decreased by 18.51% (p<0.05), which was significantly different from before use; the average depth of the nasolabial folds decreased by 21.98% (p<0.05), which was significantly different from before use; the average width of the forehead wrinkles decreased by 21.89% (p<0.05), which was significantly different from before use; the average depth of the forehead wrinkles decreased by 26.75% (p<0.05), which was significantly different from before use. The above results show that the product has anti-wrinkle effects;
[0476] After using the product for 1 week, the subjects' TEWL value decreased by 0.64%, skin hemoglobin decreased by 2.87%, a* value decreased by 2.00%, and the water content of the stratum corneum increased by 8.84% (p<0.05), which was significantly different from before use, and the glossiness increased by 3.54%;
[0477] After using the product for 2 weeks, the subjects' TEWL value decreased by 8.96% (p<0.05), which was significantly different from before use, the skin hemoglobin decreased by 4.73% (p<0.05), which was significantly different from before use, the a* value decreased by 9.02% (p<0.05), which was significantly different from before use, the water content of the stratum corneum increased by 14.61% (p<0.05), which was significantly different from before use, and the glossiness increased by 6.22% (p<0.05), which was significantly different from before use;
[0478] After using the product for 4 weeks, the subjects' TEWL value decreased by 16.59% (p<0.05), which was significantly different from before use, the skin hemoglobin decreased by 10.08% (p<0.05), which was significantly different from before use, the a* value decreased by 13.89% (p<0.05), which was significantly different from before use, the water content of the stratum corneum increased by 27.21% (p<0.05), which was significantly different from before use, and the glossiness increased by 15.10% (p<0.05), which was significantly different from before use. The above results show that the skin glossiness is improved after using the product, and the product has moisturizing and repairing effects;
[0479] After using the product for 1 week, the subjects' skin firmness F4 value decreased by 6.94%, and the elasticity index R2 value increased by 3.45%;
[0480] After using the product for 2 weeks, the skin firmness F4 value of the subjects decreased by 18.37% (p<0.05), which was significantly different from before use, and the elasticity index R2 value increased by 10.66% (p<0.05);
[0481] After using the product for 4 weeks, the subjects' skin firmness F4 value decreased by 28.82% (p<0.05), which was significantly different from before use. The elasticity index R2 value increased by 17.47% (p<0.05). The results show that the product has a firming effect.
[0482] 7. Adverse skin reactions
[0483] During the use of the test substance, none of the 30 subjects experienced any adverse skin reactions, and no subject withdrew from the trial due to personal reasons and failure to return for follow-up on time.
[0484] It should be noted that:
[0485] Although Effect Examples 2, 3, and 4 only further evaluated the product safety of the anti-wrinkle composition containing sodium DNA and RNA of batch 240124F61 through human skin patch tests, and conducted two questionnaire tests and evaluations on its sensitive skin applicability, moisturizing, firming, anti-wrinkle, repair, glossiness and other use effects, in fact, the same test and evaluation of other batches of anti-wrinkle compositions containing sodium DNA and RNA obtained according to the technical solutions provided in the above embodiments can also obtain basically the same test data, and can draw the same safety evaluation and functional effect evaluation conclusions. However, for the sake of simplicity, this specification does not list more test data.
[0486] From the review, we can see that:
[0487] The anti-wrinkle composition with sodium DNA and RNA provided by the present invention, through the organic and exquisite combination of anti-wrinkle agents, neurotransmitter inhibitors, antioxidants, moisturizers, thickeners, diluents, pH regulators and preservatives, especially sodium DNA and collagen as anti-wrinkle agents and RNA as neurotransmitter inhibitors, not only all physical and chemical indicators meet the provisions of the "Technical Specifications for Safety of Cosmetics" (2015 edition), there is no adverse reaction after use, and it meets the safety standards of cosmetics, and it is mild and non-irritating, suitable for people with sensitive skin. During use, it is refreshing and non-sticky, easy to absorb, and will not feel dry and tight. It can make people feel that their skin is more moisturized, more moisturizing, stronger, more shiny, more tender, and more hydrated and translucent. It also has obvious moisturizing effect, the skin will be more delicate, smooth, full and plump, and has the effect of improving skin roughness and fading facial dry lines and fine lines and improving facial wrinkles. It also has soothing effects such as improving skin redness, itching, burning sensation, etc., can make the skin quickly lighten lines and wrinkles and keep it smooth for a long time, so that users can restore their youthful and beautiful faces.
[0488] Since the anti-wrinkle composition with sodium DNA and RNA provided by the present invention has a clear grasp of the mechanism of wrinkle generation on human skin, a simple and clear formula, and appropriate and reasonable compatibility, the product is mild and soothing, and has excellent effects. It is not only safe, mild and non-irritating, but also suitable for people with sensitive skin. It has obvious moisturizing, anti-wrinkle, and skin firming effects, as well as skin soothing effects. It is simple to prepare and easy to use. Compared with the existing technology, it has outstanding beneficial effects and significant improvements. Therefore, it is very valuable for promotion and application.
[0489] In the description of the above manual:
[0490] The terms "this embodiment", "an embodiment of the present invention", "as shown in", "further", etc., mean that the specific features, structures, materials or characteristics described in the embodiment or case are included in at least one embodiment or case of the present invention;
[0491] In this specification, the schematic expressions of the above terms do not necessarily refer to the same embodiment or case, and the specific features, structures, materials or characteristics described may be combined or combined in any one or more embodiments or cases in a suitable manner;
[0492] In addition, under the premise that no contradiction occurs, a person of ordinary skill in the art may combine or combine the different embodiments or cases described in this specification and the features of the different embodiments or cases.
[0493] Finally, it should be noted that:
[0494] The above embodiments and various effect cases are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments and various effect cases, ordinary technicians in the field should understand that they can still modify the technical solutions recorded in the above embodiments and various effect cases, or replace part or all of the technical features therein with equivalents, and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments of the present invention. The non-essential improvements, adjustments or replacements made by technical personnel in this field according to the contents of this specification are all within the scope of protection required by the present invention.
Claims
1. An anti-wrinkle composition containing sodium DNA and RNA, which is used for rapid wrinkle reduction and long-lasting smoothness maintenance of human facial skin, characterized in that: These include polydeoxyribonucleotides and collagen as anti-wrinkle agents, ribonucleic acid as a neurotransmitter inhibitor, and antioxidants, moisturizers, thickeners, diluents, pH adjusters and preservatives that are acceptable for inclusion in cosmetics.
2. The anti-wrinkle composition comprising sodium DNA and RNA as claimed in claim 1, characterized in that: The polydeoxyribonucleotide is sodium DNA from yeast fermentation or polydeoxyribonucleotide PDRN from salmon, with an average molecular weight of 1 to 50,000 kDa; the antioxidant is p-hydroxyacetophenone, ergothioneine, astaxanthin, sodium pyrosulfite or tocopherol acetate; the moisturizer is sodium hyaluronate, trehalose, betaine, xylitol, panthenol, tetrahydromethylpyrimidine carboxylic acid, glyceryl glucoside, methyl gluceth-20, sodium PCA, amino Acid moisturizer, niacinamide, urea, diglycerin, glycerin, butylene glycol, 1,2-pentanediol, 1,3-propylene glycol, isopentyl glycol, 1,2-hexanediol, sorbitol; the thickener is sclerotium gum, xanthan gum, cellulose, crisp wave chondrus crispus or carbomer; the diluent is water; the pH adjuster is arginine, sodium hydroxide, potassium hydroxide or organic base tromethamine; the preservative is phenoxyethanol, caprylyl glycol, ethylhexylglycerin, glyceryl caprylate or caprylhydroxamic acid.
3. The anti-wrinkle composition comprising sodium DNA and RNA as claimed in claim 2, characterized in that: 100 mL of the anti-wrinkle composition containing sodium DNA and RNA contains 0.50 to 0.52 g of the polydeoxyribonucleotide, 0.10 to 0.12 g of the collagen, 0.010 to 0.012 g of the ribonucleic acid, 0.50 to 0.52 g of the p-hydroxyacetophenone, 0.05 to 0.06 g of the sodium hyaluronate, and 6.0 to 6.0 g of the glycerol. .2g, contains 4.0-4.2g of the butanediol, 3.0-3.2g of the 1,2-pentanediol, 0.10-012g of the sclerotium gum, 0.10-0.12g of the carbomer, 0.10-0.12% of the arginine, 0.30-0.32g of the glyceryl caprylate, the caprylhydroxamic acid and the 1,3-propanediol in total, and the rest is water.
4. The anti-wrinkle composition comprising sodium DNA and RNA according to any one of claims 1 to 3, characterized in that: The anti-wrinkle composition containing DNA sodium and RNA is a clear purple to purple-red transparent liquid with a pH value of 6.5-7.5 and a relative density of 1.02-1.04 at 20°C.
5. The anti-wrinkle composition comprising sodium DNA and RNA according to any one of claims 1 to 3, characterized in that: According to the requirements of Chapter 4 of the 2015 edition of the National Standard of the People's Republic of China "Technical Specifications for Safety of Cosmetics", the mercury content is ≤1mg / kg, the lead content is ≤10mg / kg, the arsenic content is ≤2mg / kg, and the cadmium content is ≤5mg / kg.
6. The anti-wrinkle composition comprising sodium DNA and RNA according to any one of claims 1 to 3, characterized in that: According to the provisions of Chapter 5 of the 2015 edition of the National Standard of the People's Republic of China "Technical Specifications for Safety of Cosmetics", the total colony count shall be ≤1000CFU / g, the total number of molds and yeasts shall be ≤100CFU / g, and the heat-resistant coliform group, Staphylococcus aureus and Pseudomonas aeruginosa shall not be detected.
7. The anti-wrinkle composition comprising sodium DNA and RNA according to any one of claims 1 to 6, characterized in that: Made by the following method: Put the diluent in a preparation pot, slowly sprinkle carbomer as a thickener, and pre-disperse sodium hyaluronate, glycerin, butylene glycol as a moisturizer and sclerotium gum as a thickener to prepare a uniformly dispersed mixture, then add the mixture to the preparation pot, stir and heat, then add 1,2-pentanediol as a moisturizer and an antioxidant, continue stirring until the materials in the preparation pot are uniform, then cool down for the first time, then add a pH adjuster to adjust the pH, cool down for the second time, then add a preservative, a neurotransmitter inhibitor, an anti-wrinkle agent and other materials as thickeners and moisturizers, continue stirring until uniform, let stand, and then filter with a sieve to obtain the product.
8. The anti-wrinkle composition comprising sodium DNA and RNA as claimed in claim 7, characterized in that: The heating temperature is 70-75°C, the first cooling temperature is 50-55°C, and the second cooling temperature is below 40°C.
9. The anti-wrinkle composition comprising sodium DNA and RNA as claimed in claim 7, characterized in that: The stirring speed is 5-50 r / min, and the filtration screen specification is 200 meshes.
10. The anti-wrinkle composition comprising sodium DNA and RNA according to claim 7, characterized in that: The preparation pot is a stainless steel steam heating pot with a stirring device.
Citation Information
Patent Citations
DNA anti-wrinkle moisturizer
CN107080706A
Small molecule polydeoxyribonucleotide and preparation and application thereof
CN110747194A
Anti-aging skin care product containing polydeoxyribonucleic acid
CN112932988A
Anti-aging composition as well as preparation method and application thereof
CN114053191A
Cited By
High-stability water-in-oil type PDRN emulsion and preparation method thereof
CN121668047A
Method for preparing microorganism-derived highly functional DNA fragment mixture, and functional composition comprising DNA fragment mixture prepared thereby
WO2026177421A1
